Nora Clarke

Nora Clarke has work experience in the field of scientific research and development. Nora worked as an Analytical Development Scientist at Resolution Therapeutics starting from March 2023. Prior to that, they worked at Imperial College London where they held two roles. First, as a Postdoctoral Researcher from November 2021 to September 2022, and second, as a PhD Student from November 2017 to October 2021. During their time at Imperial College London, Nora focused on developing a cell therapy platform technology for lung disease treatment and investigating the role of macrophages in cystic fibrosis. Nora'sexpertise includes lentiviral and non-viral delivery systems, in vivo testing, molecular analysis, and flow cytometry.

Nora Clarke has an impressive education history. Nora pursued their Bachelor's degree in Biology, General from Imperial College London from 2013 to 2016. Following this, they continued their education at the same institution and obtained a Master's degree in Gene/Genetic Therapy in the year 2017. Nora then enrolled in Imperial College London's Doctor of Philosophy (PhD) program in Cell and Gene Therapy, which they successfully completed in 2021. Prior to their undergraduate studies, they completed the International Baccalaureate program at United World College Costa Rica between 2011 and 2013.